This theory is supported by literature linking elevated inflammatory biomarkers like CRP and the neutrophil-to-lymphocyte ratio (NLR) to worse outcomes in pneumonia [17,18]. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.